Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,965 public trials 2,022 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Study to Evaluate the Efficacy and Safety of Treatment With Bendamustine in Combination With Ofatumumab in Previously Untreated Patients With Indolent B-Cell Non-Hodgkin's Lymphoma (NHL)

NCT01108341

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Birmingham Hematology and Oncology Associates, LLC Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • Hematology Oncology, P.C. Stamford, Connecticut, United States
View all 39 locations
View Trial Details
Completed

Anti-Tac for Treatment of Leukemia

NCT00001941

Conditions
Deltaretrovirus Infections, Diabetes Mellitus, Insulin-Dependent, 10, HTLV-I Infection, +19 more
Locations
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
View Trial Details
Completed

Tositumomab And Iodine I 131-Tositumomab In Patients With Relapsed Indolent Non-Hodgkin's Lymphoma

NCT00240565

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • GSK Investigational Site Calgary, Alberta, Canada
  • GSK Investigational Site Edmonton, Alberta, Canada
  • GSK Investigational Site Halifax, Nova Scotia, Canada
  • GSK Investigational Site Hamilton, Ontario, Canada
View Trial Details
Completed

An Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis Fungoides

NCT00535470

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Stanford University Medical Center Stanford, California, United States
  • Northwestern University-Dept. of Dermatology Chicago, Illinois, United States
  • Columbia University, Dept of Dermatology New York, United States
  • NYU Medical Center Dept. of Dermatology New York, United States
View Trial Details

Related conditions